Viridian Therapeutics, Inc.\DE VRDN
NASDAQ VRDN
$22.82 -0.19 (-0.83%)
At close: Oct 22, 2026 · 4:00 PM EDT

Viridian Therapeutics, Inc.\DE (VRDN) EBT Margin (2013 - 2026)

Updated

Viridian Therapeutics, Inc.\DE's EBT Margin was -44396.13% in Q2 2026, up 89917.21 percentage points from -134313.33% a year earlier and up 34865.58 percentage points from the prior quarter.

Analysis

Viridian Therapeutics, Inc.\DE (VRDN) EBT Margin (2013 - 2026) Analysis & Trends

On a trailing twelve-month basis, Viridian Therapeutics, Inc.\DE's EBT Margin was -549.91% through Jun 30, 2026, up 112097.30 percentage points year-over-year; for FY2025, it came in at -481.23%, up 88801.89 percentage points from FY2024.

  • EBT Margin shows a five-year change of +10079.54 percentage points (FY2020 to FY2025).
  • In earlier years, EBT Margin was -89283.11% in FY2024 (-13633.11 pp), -75650.00% in FY2023 (-68320.77 pp), -7329.23% in FY2022 (-4649.08 pp) and -2680.16% in FY2021 (+7880.61 pp).
  • Quarterly EBT Margin has moved between -134313.33% (Q2 2025) and -49.67% (Q3 2025) over five years.
  • Compared with a year earlier, EBT Margin has increased for four straight quarters, with an average year-over-year change of +12899.06 percentage points over the last eight quarters.
  • The best year-over-year quarter for EBT Margin over five years was Q4 2021 (a gain of 154581.24 percentage points); the worst was Q2 2023 (a drop of 64956.47 percentage points).
  • Per Business Quant data, VRDN's EBT Margin in the three quarters before Q2 2026 was -79261.70% (Q1 2026), -89575.00% (Q4 2025) and -49.67% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Eli Lilly 1,144.36 Bn 1,112.95 Bn 19.71 Bn 40.25%
2 Johnson & Johnson 635.36 Bn 555.22 Bn 17.30 Bn 0.13%
3 AbbVie 502.79 Bn 475.90 Bn 12.70 Bn 25.18%
4 Merck 356.08 Bn 310.46 Bn 12.21 Bn -4.11%
5 Novartis Ag 300.87 Bn 264.86 Bn 11.24 Bn 29.63%
6 Astrazeneca 264.31 Bn 237.99 Bn 12.86 Bn 18.19%
7 Amgen 239.07 Bn 194.47 Bn 7.24 Bn 27.53%
8 Gilead Sciences 194.50 Bn 168.70 Bn 6.22 Bn -131.41%
9 Pfizer 171.00 Bn 117.64 Bn 10.94 Bn -4.34%
10 Viridian Therapeutics, Inc.\DE 2.33 Bn -781.58 Mn - -44,396.13%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -44,396.13%
Mar 31, 2026 -79,261.70%
Dec 31, 2025 -89,575.00%
Sep 30, 2025 -49.67%
Jun 30, 2025 -134,313.33%
Mar 31, 2025 -120,661.11%
Dec 31, 2024 -110,373.61%
Sep 30, 2024 -88,946.51%
Jun 30, 2024 -90,268.06%
Mar 31, 2024 -67,419.44%
Dec 31, 2023 -92,593.06%
Sep 30, 2023 -66,194.44%
Jun 30, 2023 -76,476.39%
Mar 31, 2023 -69,541.84%
Dec 31, 2022 -43,604.76%
Sep 30, 2022 -2,418.83%
Jun 30, 2022 -11,519.92%
Mar 31, 2022 -11,894.91%
Dec 31, 2021 -13,526.17%
Sep 30, 2021 -6,751.44%
API Access

Viridian Therapeutics, Inc.\DE EBT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebt-margin&ticker=VRDN&period=max&api_key=YOUR_API_KEY